eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2007
vol. 2
 
Share:
Share:
abstract:

Review paper
The role of growth factors in pathogenesis of pancreatic cancer. Part I: Epidermal growth factor receptors (EGFR) and heparin-binding EGF-like growth factor (HB-EGF)

Marek Olakowski

Przegląd Gastroenterologiczny 2007; 2 (4): 170–174
Online publish date: 2007/08/30
View full text Get citation
 
The epidermal growth factor receptor (EGFR) family consists of a group of transmembrane proteins with an intrinsic tyrosine kinase activity. It consists of 4 members: EGFR/ErbB-1, HER2/ErbB-2, HER3/ErbB-3 and HER4/ErbB-4. Overexpression of EGFR is observed in pancreatic cancer cells in over 40% of specimens from surgically excised tumours. In patients with overexpressed EGFR, liver metastases and local recurrence are more frequently observed. A correlation between expression of EGFR and grading and staging is observed. In experimental studies the overexpression of HER2/neu protein in cells triggers proliferation and is connected with neoplasmatic transformation and metastases. Experimental studies of the usefulness of HER2/neu measurements in clinical practice give inconsistent results. It was shown that overexpression of c-erbB-3 in pancreatic cancer is connected with poor prognosis. Heparin-binding EGF-like growth factor can play a role in auto- and paracrine activation of EGFR, contributing to proliferation of pancreatic cancer cells.
keywords:

pancreatic cancer, epidermal growth factor, heparin-binding EGF-like growth factor

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.